Global Alzheimer's Disease Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 98

Published Date: 18 Mar 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

According to our (Global Info Research) latest study, the global Alzheimer's Disease Drug market size was valued at USD 3722.7 million in 2022 and is forecast to a readjusted size of USD 4113.3 million by 2029 with a CAGR of 1.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The major players in global Alzheimer’s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.

This report is a detailed and comprehensive analysis for global Alzheimer's Disease Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Alzheimer's Disease Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Alzheimer's Disease Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Alzheimer's Disease Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Alzheimer's Disease Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Alzheimer's Disease Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Alzheimer's Disease Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Allergan, Eisai, Novartis, Daiichi Sankyo and Merz Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Alzheimer's Disease Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Donepezil
    Memantine
    Rivastigmine
    Others

Market segment by Application
    Early to Moderate Stages
    Moderate to Severe Stages

Major players covered
    Allergan
    Eisai
    Novartis
    Daiichi Sankyo
    Merz Pharma
    Pfizer
    Johnson & Johnson
    Lundbeck

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Alzheimer's Disease Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Alzheimer's Disease Drug, with price, sales, revenue and global market share of Alzheimer's Disease Drug from 2018 to 2023.
Chapter 3, the Alzheimer's Disease Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alzheimer's Disease Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Alzheimer's Disease Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Alzheimer's Disease Drug.
Chapter 14 and 15, to describe Alzheimer's Disease Drug sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Alzheimer's Disease Drug
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Alzheimer's Disease Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Donepezil
        1.3.3 Memantine
        1.3.4 Rivastigmine
        1.3.5 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Alzheimer's Disease Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Early to Moderate Stages
        1.4.3 Moderate to Severe Stages
    1.5 Global Alzheimer's Disease Drug Market Size & Forecast
        1.5.1 Global Alzheimer's Disease Drug Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Alzheimer's Disease Drug Sales Quantity (2018-2029)
        1.5.3 Global Alzheimer's Disease Drug Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Allergan
        2.1.1 Allergan Details
        2.1.2 Allergan Major Business
        2.1.3 Allergan Alzheimer's Disease Drug Product and Services
        2.1.4 Allergan Alzheimer's Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Allergan Recent Developments/Updates
    2.2 Eisai
        2.2.1 Eisai Details
        2.2.2 Eisai Major Business
        2.2.3 Eisai Alzheimer's Disease Drug Product and Services
        2.2.4 Eisai Alzheimer's Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Eisai Recent Developments/Updates
    2.3 Novartis
        2.3.1 Novartis Details
        2.3.2 Novartis Major Business
        2.3.3 Novartis Alzheimer's Disease Drug Product and Services
        2.3.4 Novartis Alzheimer's Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Novartis Recent Developments/Updates
    2.4 Daiichi Sankyo
        2.4.1 Daiichi Sankyo Details
        2.4.2 Daiichi Sankyo Major Business
        2.4.3 Daiichi Sankyo Alzheimer's Disease Drug Product and Services
        2.4.4 Daiichi Sankyo Alzheimer's Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Daiichi Sankyo Recent Developments/Updates
    2.5 Merz Pharma
        2.5.1 Merz Pharma Details
        2.5.2 Merz Pharma Major Business
        2.5.3 Merz Pharma Alzheimer's Disease Drug Product and Services
        2.5.4 Merz Pharma Alzheimer's Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Merz Pharma Recent Developments/Updates
    2.6 Pfizer
        2.6.1 Pfizer Details
        2.6.2 Pfizer Major Business
        2.6.3 Pfizer Alzheimer's Disease Drug Product and Services
        2.6.4 Pfizer Alzheimer's Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Pfizer Recent Developments/Updates
    2.7 Johnson & Johnson
        2.7.1 Johnson & Johnson Details
        2.7.2 Johnson & Johnson Major Business
        2.7.3 Johnson & Johnson Alzheimer's Disease Drug Product and Services
        2.7.4 Johnson & Johnson Alzheimer's Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Johnson & Johnson Recent Developments/Updates
    2.8 Lundbeck
        2.8.1 Lundbeck Details
        2.8.2 Lundbeck Major Business
        2.8.3 Lundbeck Alzheimer's Disease Drug Product and Services
        2.8.4 Lundbeck Alzheimer's Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Lundbeck Recent Developments/Updates

3 Competitive Environment: Alzheimer's Disease Drug by Manufacturer
    3.1 Global Alzheimer's Disease Drug Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Alzheimer's Disease Drug Revenue by Manufacturer (2018-2023)
    3.3 Global Alzheimer's Disease Drug Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Alzheimer's Disease Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Alzheimer's Disease Drug Manufacturer Market Share in 2022
        3.4.2 Top 6 Alzheimer's Disease Drug Manufacturer Market Share in 2022
    3.5 Alzheimer's Disease Drug Market: Overall Company Footprint Analysis
        3.5.1 Alzheimer's Disease Drug Market: Region Footprint
        3.5.2 Alzheimer's Disease Drug Market: Company Product Type Footprint
        3.5.3 Alzheimer's Disease Drug Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Alzheimer's Disease Drug Market Size by Region
        4.1.1 Global Alzheimer's Disease Drug Sales Quantity by Region (2018-2029)
        4.1.2 Global Alzheimer's Disease Drug Consumption Value by Region (2018-2029)
        4.1.3 Global Alzheimer's Disease Drug Average Price by Region (2018-2029)
    4.2 North America Alzheimer's Disease Drug Consumption Value (2018-2029)
    4.3 Europe Alzheimer's Disease Drug Consumption Value (2018-2029)
    4.4 Asia-Pacific Alzheimer's Disease Drug Consumption Value (2018-2029)
    4.5 South America Alzheimer's Disease Drug Consumption Value (2018-2029)
    4.6 Middle East and Africa Alzheimer's Disease Drug Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Alzheimer's Disease Drug Sales Quantity by Type (2018-2029)
    5.2 Global Alzheimer's Disease Drug Consumption Value by Type (2018-2029)
    5.3 Global Alzheimer's Disease Drug Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Alzheimer's Disease Drug Sales Quantity by Application (2018-2029)
    6.2 Global Alzheimer's Disease Drug Consumption Value by Application (2018-2029)
    6.3 Global Alzheimer's Disease Drug Average Price by Application (2018-2029)

7 North America
    7.1 North America Alzheimer's Disease Drug Sales Quantity by Type (2018-2029)
    7.2 North America Alzheimer's Disease Drug Sales Quantity by Application (2018-2029)
    7.3 North America Alzheimer's Disease Drug Market Size by Country
        7.3.1 North America Alzheimer's Disease Drug Sales Quantity by Country (2018-2029)
        7.3.2 North America Alzheimer's Disease Drug Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Alzheimer's Disease Drug Sales Quantity by Type (2018-2029)
    8.2 Europe Alzheimer's Disease Drug Sales Quantity by Application (2018-2029)
    8.3 Europe Alzheimer's Disease Drug Market Size by Country
        8.3.1 Europe Alzheimer's Disease Drug Sales Quantity by Country (2018-2029)
        8.3.2 Europe Alzheimer's Disease Drug Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Alzheimer's Disease Drug Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Alzheimer's Disease Drug Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Alzheimer's Disease Drug Market Size by Region
        9.3.1 Asia-Pacific Alzheimer's Disease Drug Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Alzheimer's Disease Drug Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Alzheimer's Disease Drug Sales Quantity by Type (2018-2029)
    10.2 South America Alzheimer's Disease Drug Sales Quantity by Application (2018-2029)
    10.3 South America Alzheimer's Disease Drug Market Size by Country
        10.3.1 South America Alzheimer's Disease Drug Sales Quantity by Country (2018-2029)
        10.3.2 South America Alzheimer's Disease Drug Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Alzheimer's Disease Drug Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Alzheimer's Disease Drug Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Alzheimer's Disease Drug Market Size by Country
        11.3.1 Middle East & Africa Alzheimer's Disease Drug Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Alzheimer's Disease Drug Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Alzheimer's Disease Drug Market Drivers
    12.2 Alzheimer's Disease Drug Market Restraints
    12.3 Alzheimer's Disease Drug Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Alzheimer's Disease Drug and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Alzheimer's Disease Drug
    13.3 Alzheimer's Disease Drug Production Process
    13.4 Alzheimer's Disease Drug Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Alzheimer's Disease Drug Typical Distributors
    14.3 Alzheimer's Disease Drug Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Alzheimer's Disease Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Alzheimer's Disease Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Allergan Basic Information, Manufacturing Base and Competitors
    Table 4. Allergan Major Business
    Table 5. Allergan Alzheimer's Disease Drug Product and Services
    Table 6. Allergan Alzheimer's Disease Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Allergan Recent Developments/Updates
    Table 8. Eisai Basic Information, Manufacturing Base and Competitors
    Table 9. Eisai Major Business
    Table 10. Eisai Alzheimer's Disease Drug Product and Services
    Table 11. Eisai Alzheimer's Disease Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Eisai Recent Developments/Updates
    Table 13. Novartis Basic Information, Manufacturing Base and Competitors
    Table 14. Novartis Major Business
    Table 15. Novartis Alzheimer's Disease Drug Product and Services
    Table 16. Novartis Alzheimer's Disease Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Novartis Recent Developments/Updates
    Table 18. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
    Table 19. Daiichi Sankyo Major Business
    Table 20. Daiichi Sankyo Alzheimer's Disease Drug Product and Services
    Table 21. Daiichi Sankyo Alzheimer's Disease Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Daiichi Sankyo Recent Developments/Updates
    Table 23. Merz Pharma Basic Information, Manufacturing Base and Competitors
    Table 24. Merz Pharma Major Business
    Table 25. Merz Pharma Alzheimer's Disease Drug Product and Services
    Table 26. Merz Pharma Alzheimer's Disease Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Merz Pharma Recent Developments/Updates
    Table 28. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 29. Pfizer Major Business
    Table 30. Pfizer Alzheimer's Disease Drug Product and Services
    Table 31. Pfizer Alzheimer's Disease Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Pfizer Recent Developments/Updates
    Table 33. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 34. Johnson & Johnson Major Business
    Table 35. Johnson & Johnson Alzheimer's Disease Drug Product and Services
    Table 36. Johnson & Johnson Alzheimer's Disease Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Johnson & Johnson Recent Developments/Updates
    Table 38. Lundbeck Basic Information, Manufacturing Base and Competitors
    Table 39. Lundbeck Major Business
    Table 40. Lundbeck Alzheimer's Disease Drug Product and Services
    Table 41. Lundbeck Alzheimer's Disease Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Lundbeck Recent Developments/Updates
    Table 43. Global Alzheimer's Disease Drug Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 44. Global Alzheimer's Disease Drug Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 45. Global Alzheimer's Disease Drug Average Price by Manufacturer (2018-2023) & (USD/Unit)
    Table 46. Market Position of Manufacturers in Alzheimer's Disease Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 47. Head Office and Alzheimer's Disease Drug Production Site of Key Manufacturer
    Table 48. Alzheimer's Disease Drug Market: Company Product Type Footprint
    Table 49. Alzheimer's Disease Drug Market: Company Product Application Footprint
    Table 50. Alzheimer's Disease Drug New Market Entrants and Barriers to Market Entry
    Table 51. Alzheimer's Disease Drug Mergers, Acquisition, Agreements, and Collaborations
    Table 52. Global Alzheimer's Disease Drug Sales Quantity by Region (2018-2023) & (K Units)
    Table 53. Global Alzheimer's Disease Drug Sales Quantity by Region (2024-2029) & (K Units)
    Table 54. Global Alzheimer's Disease Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 55. Global Alzheimer's Disease Drug Consumption Value by Region (2024-2029) & (USD Million)
    Table 56. Global Alzheimer's Disease Drug Average Price by Region (2018-2023) & (USD/Unit)
    Table 57. Global Alzheimer's Disease Drug Average Price by Region (2024-2029) & (USD/Unit)
    Table 58. Global Alzheimer's Disease Drug Sales Quantity by Type (2018-2023) & (K Units)
    Table 59. Global Alzheimer's Disease Drug Sales Quantity by Type (2024-2029) & (K Units)
    Table 60. Global Alzheimer's Disease Drug Consumption Value by Type (2018-2023) & (USD Million)
    Table 61. Global Alzheimer's Disease Drug Consumption Value by Type (2024-2029) & (USD Million)
    Table 62. Global Alzheimer's Disease Drug Average Price by Type (2018-2023) & (USD/Unit)
    Table 63. Global Alzheimer's Disease Drug Average Price by Type (2024-2029) & (USD/Unit)
    Table 64. Global Alzheimer's Disease Drug Sales Quantity by Application (2018-2023) & (K Units)
    Table 65. Global Alzheimer's Disease Drug Sales Quantity by Application (2024-2029) & (K Units)
    Table 66. Global Alzheimer's Disease Drug Consumption Value by Application (2018-2023) & (USD Million)
    Table 67. Global Alzheimer's Disease Drug Consumption Value by Application (2024-2029) & (USD Million)
    Table 68. Global Alzheimer's Disease Drug Average Price by Application (2018-2023) & (USD/Unit)
    Table 69. Global Alzheimer's Disease Drug Average Price by Application (2024-2029) & (USD/Unit)
    Table 70. North America Alzheimer's Disease Drug Sales Quantity by Type (2018-2023) & (K Units)
    Table 71. North America Alzheimer's Disease Drug Sales Quantity by Type (2024-2029) & (K Units)
    Table 72. North America Alzheimer's Disease Drug Sales Quantity by Application (2018-2023) & (K Units)
    Table 73. North America Alzheimer's Disease Drug Sales Quantity by Application (2024-2029) & (K Units)
    Table 74. North America Alzheimer's Disease Drug Sales Quantity by Country (2018-2023) & (K Units)
    Table 75. North America Alzheimer's Disease Drug Sales Quantity by Country (2024-2029) & (K Units)
    Table 76. North America Alzheimer's Disease Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 77. North America Alzheimer's Disease Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 78. Europe Alzheimer's Disease Drug Sales Quantity by Type (2018-2023) & (K Units)
    Table 79. Europe Alzheimer's Disease Drug Sales Quantity by Type (2024-2029) & (K Units)
    Table 80. Europe Alzheimer's Disease Drug Sales Quantity by Application (2018-2023) & (K Units)
    Table 81. Europe Alzheimer's Disease Drug Sales Quantity by Application (2024-2029) & (K Units)
    Table 82. Europe Alzheimer's Disease Drug Sales Quantity by Country (2018-2023) & (K Units)
    Table 83. Europe Alzheimer's Disease Drug Sales Quantity by Country (2024-2029) & (K Units)
    Table 84. Europe Alzheimer's Disease Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 85. Europe Alzheimer's Disease Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 86. Asia-Pacific Alzheimer's Disease Drug Sales Quantity by Type (2018-2023) & (K Units)
    Table 87. Asia-Pacific Alzheimer's Disease Drug Sales Quantity by Type (2024-2029) & (K Units)
    Table 88. Asia-Pacific Alzheimer's Disease Drug Sales Quantity by Application (2018-2023) & (K Units)
    Table 89. Asia-Pacific Alzheimer's Disease Drug Sales Quantity by Application (2024-2029) & (K Units)
    Table 90. Asia-Pacific Alzheimer's Disease Drug Sales Quantity by Region (2018-2023) & (K Units)
    Table 91. Asia-Pacific Alzheimer's Disease Drug Sales Quantity by Region (2024-2029) & (K Units)
    Table 92. Asia-Pacific Alzheimer's Disease Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 93. Asia-Pacific Alzheimer's Disease Drug Consumption Value by Region (2024-2029) & (USD Million)
    Table 94. South America Alzheimer's Disease Drug Sales Quantity by Type (2018-2023) & (K Units)
    Table 95. South America Alzheimer's Disease Drug Sales Quantity by Type (2024-2029) & (K Units)
    Table 96. South America Alzheimer's Disease Drug Sales Quantity by Application (2018-2023) & (K Units)
    Table 97. South America Alzheimer's Disease Drug Sales Quantity by Application (2024-2029) & (K Units)
    Table 98. South America Alzheimer's Disease Drug Sales Quantity by Country (2018-2023) & (K Units)
    Table 99. South America Alzheimer's Disease Drug Sales Quantity by Country (2024-2029) & (K Units)
    Table 100. South America Alzheimer's Disease Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 101. South America Alzheimer's Disease Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 102. Middle East & Africa Alzheimer's Disease Drug Sales Quantity by Type (2018-2023) & (K Units)
    Table 103. Middle East & Africa Alzheimer's Disease Drug Sales Quantity by Type (2024-2029) & (K Units)
    Table 104. Middle East & Africa Alzheimer's Disease Drug Sales Quantity by Application (2018-2023) & (K Units)
    Table 105. Middle East & Africa Alzheimer's Disease Drug Sales Quantity by Application (2024-2029) & (K Units)
    Table 106. Middle East & Africa Alzheimer's Disease Drug Sales Quantity by Region (2018-2023) & (K Units)
    Table 107. Middle East & Africa Alzheimer's Disease Drug Sales Quantity by Region (2024-2029) & (K Units)
    Table 108. Middle East & Africa Alzheimer's Disease Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 109. Middle East & Africa Alzheimer's Disease Drug Consumption Value by Region (2024-2029) & (USD Million)
    Table 110. Alzheimer's Disease Drug Raw Material
    Table 111. Key Manufacturers of Alzheimer's Disease Drug Raw Materials
    Table 112. Alzheimer's Disease Drug Typical Distributors
    Table 113. Alzheimer's Disease Drug Typical Customers
List of Figures
    Figure 1. Alzheimer's Disease Drug Picture
    Figure 2. Global Alzheimer's Disease Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Alzheimer's Disease Drug Consumption Value Market Share by Type in 2022
    Figure 4. Donepezil Examples
    Figure 5. Memantine Examples
    Figure 6. Rivastigmine Examples
    Figure 7. Others Examples
    Figure 8. Global Alzheimer's Disease Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 9. Global Alzheimer's Disease Drug Consumption Value Market Share by Application in 2022
    Figure 10. Early to Moderate Stages Examples
    Figure 11. Moderate to Severe Stages Examples
    Figure 12. Global Alzheimer's Disease Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global Alzheimer's Disease Drug Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Alzheimer's Disease Drug Sales Quantity (2018-2029) & (K Units)
    Figure 15. Global Alzheimer's Disease Drug Average Price (2018-2029) & (USD/Unit)
    Figure 16. Global Alzheimer's Disease Drug Sales Quantity Market Share by Manufacturer in 2022
    Figure 17. Global Alzheimer's Disease Drug Consumption Value Market Share by Manufacturer in 2022
    Figure 18. Producer Shipments of Alzheimer's Disease Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 19. Top 3 Alzheimer's Disease Drug Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Top 6 Alzheimer's Disease Drug Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Global Alzheimer's Disease Drug Sales Quantity Market Share by Region (2018-2029)
    Figure 22. Global Alzheimer's Disease Drug Consumption Value Market Share by Region (2018-2029)
    Figure 23. North America Alzheimer's Disease Drug Consumption Value (2018-2029) & (USD Million)
    Figure 24. Europe Alzheimer's Disease Drug Consumption Value (2018-2029) & (USD Million)
    Figure 25. Asia-Pacific Alzheimer's Disease Drug Consumption Value (2018-2029) & (USD Million)
    Figure 26. South America Alzheimer's Disease Drug Consumption Value (2018-2029) & (USD Million)
    Figure 27. Middle East & Africa Alzheimer's Disease Drug Consumption Value (2018-2029) & (USD Million)
    Figure 28. Global Alzheimer's Disease Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 29. Global Alzheimer's Disease Drug Consumption Value Market Share by Type (2018-2029)
    Figure 30. Global Alzheimer's Disease Drug Average Price by Type (2018-2029) & (USD/Unit)
    Figure 31. Global Alzheimer's Disease Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 32. Global Alzheimer's Disease Drug Consumption Value Market Share by Application (2018-2029)
    Figure 33. Global Alzheimer's Disease Drug Average Price by Application (2018-2029) & (USD/Unit)
    Figure 34. North America Alzheimer's Disease Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 35. North America Alzheimer's Disease Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 36. North America Alzheimer's Disease Drug Sales Quantity Market Share by Country (2018-2029)
    Figure 37. North America Alzheimer's Disease Drug Consumption Value Market Share by Country (2018-2029)
    Figure 38. United States Alzheimer's Disease Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Canada Alzheimer's Disease Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Mexico Alzheimer's Disease Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Europe Alzheimer's Disease Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 42. Europe Alzheimer's Disease Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 43. Europe Alzheimer's Disease Drug Sales Quantity Market Share by Country (2018-2029)
    Figure 44. Europe Alzheimer's Disease Drug Consumption Value Market Share by Country (2018-2029)
    Figure 45. Germany Alzheimer's Disease Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. France Alzheimer's Disease Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. United Kingdom Alzheimer's Disease Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Russia Alzheimer's Disease Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Italy Alzheimer's Disease Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Asia-Pacific Alzheimer's Disease Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 51. Asia-Pacific Alzheimer's Disease Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 52. Asia-Pacific Alzheimer's Disease Drug Sales Quantity Market Share by Region (2018-2029)
    Figure 53. Asia-Pacific Alzheimer's Disease Drug Consumption Value Market Share by Region (2018-2029)
    Figure 54. China Alzheimer's Disease Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Japan Alzheimer's Disease Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Korea Alzheimer's Disease Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. India Alzheimer's Disease Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Southeast Asia Alzheimer's Disease Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Australia Alzheimer's Disease Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. South America Alzheimer's Disease Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 61. South America Alzheimer's Disease Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 62. South America Alzheimer's Disease Drug Sales Quantity Market Share by Country (2018-2029)
    Figure 63. South America Alzheimer's Disease Drug Consumption Value Market Share by Country (2018-2029)
    Figure 64. Brazil Alzheimer's Disease Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Argentina Alzheimer's Disease Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Middle East & Africa Alzheimer's Disease Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 67. Middle East & Africa Alzheimer's Disease Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 68. Middle East & Africa Alzheimer's Disease Drug Sales Quantity Market Share by Region (2018-2029)
    Figure 69. Middle East & Africa Alzheimer's Disease Drug Consumption Value Market Share by Region (2018-2029)
    Figure 70. Turkey Alzheimer's Disease Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Egypt Alzheimer's Disease Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Saudi Arabia Alzheimer's Disease Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. South Africa Alzheimer's Disease Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. Alzheimer's Disease Drug Market Drivers
    Figure 75. Alzheimer's Disease Drug Market Restraints
    Figure 76. Alzheimer's Disease Drug Market Trends
    Figure 77. Porters Five Forces Analysis
    Figure 78. Manufacturing Cost Structure Analysis of Alzheimer's Disease Drug in 2022
    Figure 79. Manufacturing Process Analysis of Alzheimer's Disease Drug
    Figure 80. Alzheimer's Disease Drug Industrial Chain
    Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 82. Direct Channel Pros & Cons
    Figure 83. Indirect Channel Pros & Cons
    Figure 84. Methodology
    Figure 85. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Alzheimer's Disease Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Alzheimer's Disease Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Alzheimer's Disease Drug market size was valued at USD 3722.7 million in 2023 and is forecast to a readjusted size of USD 4113.3 million by 2030 with a CAGR of 1.4% during review period.

Global Alzheimer's Disease Drug Supply, Demand and Key Producers, 2024-2030

Global Alzheimer's Disease Drug Supply, Demand and Key Producers, 2024-2030

date 18 Feb 2024

date Pharma & Healthcare

The global Alzheimer's Disease Drug market size is expected to reach $ 4113.3 million by 2030, rising at a market growth of 1.4% CAGR during the forecast period (2024-2030).

Product Tags

Alzheimer's Disease Drug

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>